We have a track record of innovation, problem solving and exceptional client service. Read on to learn more about how we accelerate access to innovative medicines across the lifecycle.
Clinical Trial Sourcing
Read the case study to learn how Clinigen provided an innovative comparator drug sourcing solution to reduce trial costs by 60% for the investigator.
Learn how Clinigen's On-Demand comparator sourcing model benefited a recent multi-country global clinical trial for a large pharmaceutical company.
Clinical Supplies Management
Read the case study to discover how Clinigen provided a viable packaging and labelling option in compliance with a trial's ultralow cold chain requirements.
Discover how Clinigen created a tailored Direct-to-Patient shipping solution for a sponsor, enabling quick, efficient turnarounds.
Learn how Clinigen's On-Demand method helped a sponsor to package and label an Investigational Medicinal Product (IMP) within 48 hours.
Learn how Clinigen's biomedical sample management expertise provided an integrated solution for a client's complex global study, improving traceability and reducing risks and costs.
Learn how Clinigen provided a customised and sound clinical supply strategy to investigators using a product from a top 10 pharmaceutical company.
Learn how Clinigen used it's Qualified Person (QP) expertise to help a sponsor's contract manufacturing organization (CMO) in China import an investigational medicinal product (IMP) into the EU.
Managed Access
Read the case study to discover how Clinigen enabled the company to provide pre-launch access to more than 5,000 patients with unmet medical needs and ensure fair and equitable access across all countries and populations.
Read the case study to discover how Clinigen enabled the company to provide pre-commercial access to 400 patients across Europe.
Read the case study to learn how Clinigen worked with 300 healthcare professionals to provide treatment to 950 patients.
Read the case study to find out how Clinigen ensured patients were not negatively impacted by the closure of the trial.
Read the case study to understand how Clinigen provided access to over 130 patients and implemented a sustainable and self-funding program that could be continued for many years where needed.
Read the case study to learn how the ongoing program gave access to 10,000 patients globally on a named-patient basis where there was a clear unmet medical need.
Read the case study to learn how Clinigen provided the treatment free of charge under Early Access regulations in the US.